Richard W. Mott, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 95,000 shares at $23.57 ($2.2M) on 2022-10-31, disclosed to the SEC on 2022-11-01.
Open-market sale of $2.2M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TMCI | BUY | 2024-05-13 | $1.1M | — | Filing → |
| TMCI | SELL | 2023-04-10 | $105K | — | Filing → |
| TMCI | SELL | 2023-04-05 | $415K | — | Filing → |